HNGE SEC Filing News — Hinge Health, Inc.

Latest SEC filings for Hinge Health, Inc. (HNGE) explained in plain English. Covers insider buying and selling (Form 4), proposed insider sales (Form 144), material company events (8-K), and quarterly & annual reports (10-Q / 10-K). StrongBuyAnalytics provides navigation and brief excerpts or summaries; original filings remain at the SEC/source links and were authored by their filers, not StrongBuyAnalytics. Filing dates shown are source dates. Coverage and detection can be delayed or incomplete because of SEC availability, amendments, parsing, caching, or outages. Latest source filing date shown: 2026-10-14.

Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founde…
Sector: Healthcare Industry: Health Information Services Market Cap: $8.4B
20
Total Filings
0
Bullish Classifications
12
Bearish Classifications
8
Insider Transactions
0
Material Events (8-K)
0
Periodic Reports
Rule-based classifications for HNGE currently lean bearish. Of the 20 filing records displayed, 12 carry bearish classifications (such as insider sales or negative 8-K disclosures) versus 0 bullish. This does not necessarily signal fundamental deterioration — insiders sell for many reasons — but it is worth monitoring alongside the company's core financial metrics.
HNGE Filing Activity Snapshot 2026-09-16 — 2026-10-14
Insider Transactions (Form 4)
0 buys vs 5 sells
Net insider selling in this period — insiders sell for many reasons beyond conviction.
Largest Form 144 Filing
$78.65M
Insight Venture Partners X, L.P. · 2026-10-14
749,091 shares · Form 144
Form 144 Notices
12
Proposed insider sales filed — Form 144 is a notice of intent, not a confirmed transaction. Actual sales are confirmed via Form 4.
Insider Transactions 8 · Forms 3, 4 and 5

A Form 4 is filed within two business days of a company insider — an officer, a director, or a holder of more than ten percent of the stock — changing their position in the shares. All 8 filings in this group are Form 4s for Hinge Health, Inc.

The difficulty with reading these filings as a group is that a single form type covers transactions that mean entirely different things. An executive spending their own money to buy stock and an executive having shares withheld to pay tax on a vesting grant both appear as a Form 4. Every filing below is therefore tagged with the nature of the underlying transaction, taken from the transaction code reported on the form itself.

Across the 8 insider filings shown, the breakdown is 5 open-market sale, 2 tax withholding and 1 compensation award. 5 of them involved a discretionary open-market trade; the rest are compensation and administrative mechanics.

What each transaction type means

Open-market sale ×5
The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.
Tax withholding ×2
Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.
Compensation award ×1
Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.
Form 4 Open-market sale Insider Selling 2026-10-13

HNGE insider Budge James (Chief Financial Officer) sold 47,720 shares (~$4.92M)

Budge James, listed as Chief Financial Officer at Hinge Health, Inc., reported an open-market sale of 47,720 HNGE shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 2,100 $101.53 $213.2K
S Open-market sale 21,702 $102.54 $2.23M
S Open-market sale 14,498 $103.48 $1.50M
S Open-market sale 9,420 $104.33 $982.8K
Filing: Form 4 (Insider Transaction) Insider: Budge James (Chief Financial Officer) Shares: 47,720 Est. Value: $4.92M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-10-13

HNGE insider Mecklenburg Gabriel M.I. (Director) sold 200,000 shares (~$20.63M)

Mecklenburg Gabriel M.I., listed as Director at Hinge Health, Inc., reported an open-market sale of 200,000 HNGE shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
C Derivative conversion 200,000 — —
S Open-market sale 8,642 $101.53 $877.4K
S Open-market sale 91,502 $102.53 $9.38M
S Open-market sale 59,988 $103.48 $6.21M
S Open-market sale 39,868 $104.34 $4.16M
C Derivative conversion derivative · Class B Common Stock 200,000 — —
Filing: Form 4 (Insider Transaction) Insider: Mecklenburg Gabriel M.I. (Director) Shares: 200,000 Est. Value: $20.63M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-10-07

HNGE insider Perez Daniel Antonio (Director, CEO & Co-Founder, 10% Owner) sold 4,100 shares (~$410.8K)

Perez Daniel Antonio, listed as Director, CEO & Co-Founder, 10% Owner at Hinge Health, Inc., reported an open-market sale of 4,100 HNGE shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
C Derivative conversion 4,100 — —
S Open-market sale 4,100 $100.20 $410.8K
C Derivative conversion derivative · Class B Common Stock 4,100 — —
Filing: Form 4 (Insider Transaction) Insider: Perez Daniel Antonio (Director, CEO & Co-Founder, 10% Owner) Shares: 4,100 Est. Value: $410.8K
View on SEC EDGAR → Open Filing Document →
Form 4 Compensation award Tax / Compensation Filing 2026-10-06

HNGE insider Form 4 filed for equity award, exercise, or tax withholding

Sloat Tyler (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were granted as compensation rather than purchased. No cash changed hands, so the filing reflects a pay decision by the company, not a judgement about the price.

Transactions reported on this filing
Code Nature Shares Price Value
A Compensation award 175 $92.56 $16.2K
Filing: Form 4 (Insider Transaction) Insider: Sloat Tyler (Director) Shares: 175
View on SEC EDGAR → Open Filing Document →
Form 4 Tax withholding Tax / Compensation Filing 2026-10-01

HNGE insider Form 4 filed for equity award, exercise, or tax withholding

Pursley James (President) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 831 $97.24 $80.8K
Filing: Form 4 (Insider Transaction) Insider: Pursley James (President) Shares: 831
View on SEC EDGAR → Open Filing Document →
Form 4 Tax withholding Tax / Compensation Filing 2026-10-01

HNGE insider Form 4 filed for equity award, exercise, or tax withholding

Budge James (Chief Financial Officer) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

Shares were withheld by the company to settle tax due when equity vested. This is an automatic administrative step and not a decision to sell.

Transactions reported on this filing
Code Nature Shares Price Value
F Tax withholding on vested shares 4,614 $97.24 $448.7K
Filing: Form 4 (Insider Transaction) Insider: Budge James (Chief Financial Officer) Shares: 4,614
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-23

HNGE insider Pursley James (President) sold 33,000 shares (~$3.11M)

Pursley James, listed as President at Hinge Health, Inc., reported an open-market sale of 33,000 HNGE shares in a Form 4 filing. This is a confirmed insider sale, not just a proposed sale notice.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 9,065 $93.37 $846.4K
S Open-market sale 23,135 $94.40 $2.18M
S Open-market sale 800 $95.10 $76.1K
Filing: Form 4 (Insider Transaction) Insider: Pursley James (President) Shares: 33,000 Est. Value: $3.11M
View on SEC EDGAR → Open Filing Document →
Form 4 Open-market sale Insider Selling 2026-09-16

HNGE insider Form 4 filed for equity award, exercise, or tax withholding

Robinson Elliott (Director) filed a Form 4 covering compensation-related activity such as stock awards, option exercises, conversions, or tax withholding. These filings are usually neutral.

The insider sold shares on the open market. Sales may be discretionary or executed automatically under a pre-arranged Rule 10b5-1 trading plan, and a Form 4 does not always make clear which applies.

Transactions reported on this filing
Code Nature Shares Price Value
S Open-market sale 0 — —
Filing: Form 4 (Insider Transaction) Insider: Robinson Elliott (Director)
View on SEC EDGAR → Open Filing Document →
Proposed Insider Sales 12 · Form 144

A Form 144 is a notice of intent to sell restricted or control securities. It is not a record that anything was sold. Hinge Health, Inc. has 12 such notices in this period.

The distinction matters because a Form 144 is frequently reported as though it were a completed insider sale. The filer may sell all of the shares covered, some of them, or none at all, and there is no obligation to update the notice either way. A sale that is actually executed by an officer or director shows up separately on a Form 4, which is the filing to check before treating a proposed sale as a real one.

Form 144 Proposed Insider Sale 2026-10-14

HNGE Form 144 filed for proposed insider sale by Insight Venture Partners X (Co-Investors), L.P. (17,825 shares) ~$1.87M

Insight Venture Partners X (Co-Investors), L.P. filed a Form 144 with the SEC indicating intent to sell HNGE (Hinge Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Insight Venture Partners X (Co-Investors), L.P. Shares: 17,825 Est. Value: $1.87M
View on SEC EDGAR → Open Filing Document →
Form 144 Large Proposed Insider Sale 2026-10-14

HNGE Form 144 filed for proposed insider sale by Insight Venture Partners (Delaware) X, L.P. (118,822 shares) ~$12.48M

Insight Venture Partners (Delaware) X, L.P. filed a Form 144 with the SEC indicating intent to sell HNGE (Hinge Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: Insight Venture Partners (Delaware) X, L.P. Shares: 118,822 Est. Value: $12.48M
View on SEC EDGAR → Open Filing Document →
Form 144 Large Proposed Insider Sale 2026-10-14

HNGE Form 144 filed for proposed insider sale by Insight Venture Partners X, L.P. (749,091 shares) ~$78.65M

Insight Venture Partners X, L.P. filed a Form 144 with the SEC indicating intent to sell HNGE (Hinge Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: Insight Venture Partners X, L.P. Shares: 749,091 Est. Value: $78.65M
View on SEC EDGAR → Open Filing Document →
Form 144 Large Proposed Insider Sale 2026-10-14

HNGE Form 144 filed for proposed insider sale by Insight Venture Partners (Cayman) X, L.P. (614,262 shares) ~$64.50M

Insight Venture Partners (Cayman) X, L.P. filed a Form 144 with the SEC indicating intent to sell HNGE (Hinge Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: Insight Venture Partners (Cayman) X, L.P. Shares: 614,262 Est. Value: $64.50M
View on SEC EDGAR → Open Filing Document →
Form 144 Large Proposed Insider Sale 2026-10-13

HNGE Form 144 filed for proposed insider sale by GABRIEL MECKLENBURG (200,000 shares) ~$20.58M

GABRIEL MECKLENBURG filed a Form 144 with the SEC indicating intent to sell HNGE (Hinge Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: GABRIEL MECKLENBURG Shares: 200,000 Est. Value: $20.58M
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-10-13

HNGE Form 144 filed for proposed insider sale by JAMES BUDGE (47,720 shares) ~$4.91M

JAMES BUDGE filed a Form 144 with the SEC indicating intent to sell HNGE (Hinge Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: JAMES BUDGE Shares: 47,720 Est. Value: $4.91M
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-10-06

HNGE Form 144 filed for proposed insider sale by DANIEL PEREZ (4,100 shares) ~$403.2K

DANIEL PEREZ filed a Form 144 with the SEC indicating intent to sell HNGE (Hinge Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: DANIEL PEREZ Shares: 4,100 Est. Value: $403.2K
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-30

HNGE Form 144 filed for proposed insider sale by Insight Venture Partners X (Co-Investors), L.P. (11,587 shares) ~$1.14M

Insight Venture Partners X (Co-Investors), L.P. filed a Form 144 with the SEC indicating intent to sell HNGE (Hinge Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: Insight Venture Partners X (Co-Investors), L.P. Shares: 11,587 Est. Value: $1.14M
View on SEC EDGAR → Open Filing Document →
Form 144 Large Proposed Insider Sale 2026-09-30

HNGE Form 144 filed for proposed insider sale by Insight Venture Partners (Delaware) X, L.P. (77,248 shares) ~$7.57M

Insight Venture Partners (Delaware) X, L.P. filed a Form 144 with the SEC indicating intent to sell HNGE (Hinge Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: Insight Venture Partners (Delaware) X, L.P. Shares: 77,248 Est. Value: $7.57M
View on SEC EDGAR → Open Filing Document →
Form 144 Large Proposed Insider Sale 2026-09-30

HNGE Form 144 filed for proposed insider sale by Insight Venture Partners X, L.P. (486,991 shares) ~$47.73M

Insight Venture Partners X, L.P. filed a Form 144 with the SEC indicating intent to sell HNGE (Hinge Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: Insight Venture Partners X, L.P. Shares: 486,991 Est. Value: $47.73M
View on SEC EDGAR → Open Filing Document →
Form 144 Large Proposed Insider Sale 2026-09-30

HNGE Form 144 filed for proposed insider sale by Insight Venture Partners (Cayman) X, L.P. (399,338 shares) ~$39.14M

Insight Venture Partners (Cayman) X, L.P. filed a Form 144 with the SEC indicating intent to sell HNGE (Hinge Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4. The proposed dollar value is large enough to merit attention.

Filing: Form 144 (Proposed Sale Notice) Insider: Insight Venture Partners (Cayman) X, L.P. Shares: 399,338 Est. Value: $39.14M
View on SEC EDGAR → Open Filing Document →
Form 144 Proposed Insider Sale 2026-09-21

HNGE Form 144 filed for proposed insider sale by JAMES PURSLEY (33,000 shares) ~$3.13M

JAMES PURSLEY filed a Form 144 with the SEC indicating intent to sell HNGE (Hinge Health, Inc.) shares. Form 144 reflects a proposed sale, not a completed transaction. The actual execution, if any, would typically appear later in a Form 4.

Filing: Form 144 (Proposed Sale Notice) Insider: JAMES PURSLEY Shares: 33,000 Est. Value: $3.13M
View on SEC EDGAR → Open Filing Document →

How we classify Hinge Health, Inc.'s filings

Straight from EDGAR

Each displayed record links to an original source document. StrongBuyAnalytics provides navigation and brief excerpts or summaries, not the filing itself. Parsing may omit context or contain errors, so read the original document in full.

Transaction codes, not guesswork

The nature shown on each insider filing comes from the transaction code the filer entered on the form itself — P for an open-market purchase, A for a compensation award, F for shares withheld to pay tax, M for an option exercise. Where one filing contains several codes, the transaction table lists them line by line.

Why the distinction matters

Insider activity is routinely summarised as buying or selling, which flattens together decisions that mean very different things. Shares withheld for tax on a vesting grant are an automatic administrative step; shares bought on the open market are someone committing their own money at the current price.

What this page does not tell you

A filing records what happened, not why. Form 4 does not always disclose whether a sale was executed under a pre-arranged Rule 10b5-1 plan, and no single filing is a basis for a decision on HNGE. Read these alongside the fundamentals rather than in isolation.

Frequently Asked Questions — HNGE SEC Filings

More Tools for HNGE

HNGE Full Stock Analysis HNGE Live Chart Institutional Ownership Earnings Calendar Options Flow Scanner Semiconductor Demand Zone Tracker Sector Scanner Browse All Stocks

Want deeper HNGE analysis?

View valuation, growth metrics, the rule-based stock-page score, demand zones, peer comparison, and more — all on the HNGE stock analysis page.

HNGE Full Analysis
Publisher, sources & limitations — September 15, 2026. StrongBuyAnalytics provides navigation and brief excerpts or summaries for educational use. Original filings remain at SEC EDGAR or other displayed source links; StrongBuyAnalytics does not author them. Filing dates are source dates, not publication dates for this page. Coverage can be delayed, incomplete, amended, or unavailable because of SEC/source availability, parsing, caching, or outages. Verify every material statement in the original filing.
Data Sources · Methodology · AI Disclosure · Corrections Policy · Disclaimer